文献速递血液透析通路

种族与社会经济状况与血液透析血管通路结局的关联

Association of Race and Socioeconomic Status with Hemodialysis Arteriovenous Access Outcomes.
PubMed 文献 · Ann Vasc Surg · 2026-10-06

本研究利用VQI数据库回顾性分析2016至2023年间77,544例接受AVF或AVG创建的成人患者,按种族和社区劣势(ADI四分位)评估通路结局差异。结果显示白人患者AVF成熟延迟风险高于黑人(aOR 1.43),黑人患者9个月通畅率较低(86.4% vs 88.2%),最劣势社区(Q4)患者9个月死亡风险显著高于最优势社区(aOR 1.56)。

要点

  • 白人患者AVF成熟延迟风险高于黑人患者(aOR 1.43,95%CI 1.21-1.70)。
  • 黑人患者9个月通路通畅率低于白人(86.4% vs 88.2%,p=0.003)。
  • 最劣势社区(Q4)患者9个月死亡风险显著高于Q1(aOR 1.56,95%CI 1.46-1.67)。

核心结论

  • 血液透析血管通路结局在种族和社会经济状况间存在显著差异。
  • 弱势社区患者成熟延迟和死亡率更高,黑人和美洲印第安/阿拉斯加原住民患者通畅率更差且AVG使用更多。

研究设计与样本

  • 回顾性研究,使用VQI数据库纳入2016至2023年接受AVF或AVG创建的成人患者共77,544例(平均年龄62.2岁,43.4%女性)。

主要发现

  • 白人患者AVF成熟延迟风险高于黑人患者(aOR 1.43,95%CI 1.21-1.70,p<0.001)。
  • 术后即刻出血白人低于黑人(0.6% vs 0.9%;OR 0.58,95%CI 0.43-0.79,p<0.001),Q4低于Q1(0.5% vs 1.2%;OR 0.36,95%CI 0.25-0.53,p<0.001)。
  • 9个月通路通畅率黑人低于白人(86.4% vs 88.2%,p=0.003),且随ADI变化(p<0.001),Q1最高(88.7%)。
  • 9个月未调整死亡率白人最高(28% vs 黑人21%,p<0.001),调整后仅亚洲种族独立保护(OR 0.41,95%CI 0.35-0.47,p<0.001 vs 黑人)。
  • Q4患者9个月死亡率显著高于Q1(aOR 1.56,95%CI 1.46-1.67,p<0.001)。

临床怎么用

  • 应关注弱势社区和少数种族透析患者的血管通路结局差异,针对性优化通路规划与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Arteriovenous access is essential for long-term hemodialysis. The creation and maintenance of arteriovenous fistula (AVF) or arteriovenous graft (AVG) are critical for effective dialysis and minimizing complications. However, the influence of race and social determinants of health on presentation, management, and outcomes has not been well evaluated. This study uses the Vascular Quality Initiative (VQI) database to evaluate disparities in vascular access outcomes by race and community-level disadvantage. METHODS: We conducted a retrospective study using the VQI database to identify adults who underwent AVF or AVG creation for hemodialysis between 2016 and 2023. The Area Deprivation Index (ADI), a validated measure of neighborhood socioeconomic disadvantage incorporating income, education, employment, and housing quality, was categorized into quartiles from least (Q1) to most disadvantaged (Q4). Patients without follow-up data, recorded complications, or ADI information were excluded. Predisposing factors and postoperative outcomes considering race and ADI were analyzed. Group comparisons were performed using chi-square tests and t-tests. Multivariable logistic regression adjusted for demographic and clinical covariates was used to assess associations. All analyses were conducted using SPSS version 30. RESULTS: A total of 77,544 patients were included (mean age 62.2 years, 43.4% female). White patients represented the largest racial group (51.5%, n=39,959), and 29.5% (n=22,850) were from the most disadvantaged ADI quartile. AVF maturation was more delayed in White vs Black patients (adjusted OR 1.43, 95% CI: 1.21-1.70, p<0.001). Immediate postoperative bleeding was less common in White vs Black patients (0.6% vs 0.9%; OR 0.58,0.43-0.79, p<0.001) and less frequent in Q4 vs Q1 (0.5% vs 1.2%; OR 0.36, 0.25-0.53, p<0.001). At 9 months, access patency was lower in Black vs White patients (86.4% vs 88.2%, p=0.003) and varied by ADI (p<0.001), with Q1 achieving the highest patency (88.7%). Nine-month mortality was highest in White patients (28% vs 21% in Black, p<0.001 unadjusted); however, only Asian race remained independently protective after adjustment (OR 0.41, 0.35-0.47, p<0.001 vs Black). Patients in Q4 had significantly higher 9-month mortality compared to Q1 (adjusted OR 1.56, 1.46-1.67, p<0.001). CONCLUSIONS: Significant disparities in hemodialysis access outcomes exist by race and socioeconomic status. Patients in disadvantaged areas experienced higher rates of maturation delay and mortality. Black and American Indian/Alaskan Native patients had worse patency and greater AVG use. Structural and social factors strongly influence vascular access outcomes, underscoring the need for targeted interventions to improve equity in hemodialysis care.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ranjbar K, Jang J, Rodrigues R, et al. Association of Race and Socioeconomic Status with Hemodialysis Arteriovenous Access Outcomes. Ann Vasc Surg. 2026. PMID: 42838482. doi:10.1016/j.avsg.2026.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。